“The Good, the Bad, the Ugly”: Experimental Human Studies of Cbd, Thc, and THCV

Englund, Amir; Morrison, Paul; Atakan, Zerrin; Kralj, Aleksandra; Stone, James; Nottage, Judith; Murray, Robin M.

doi:10.1016/s0920-9964(14)70108-2

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other cannabinoids mitigate these effects. Specifically, cannabidiol (CBD) has been demonstrated to have neuro-protective, anxiolytic and antipsychotic effects (Englund et al , 2013; Englund et al , 2014; Morgan et al , 2010; Morgan and Curran, 2008; Fakhoury, 2016). Prohibition makes it impossible to regulate to ensure a lower-risk substance, and leaves users with no way of knowing the potency of what they are consuming.…”

Section: Mental Health and Addictionmentioning

confidence: 99%

More harm than good? Cannabis, harm and the misuse of drugs act

Potter

Wells²

2021

DAT

View full text Add to dashboard Cite

Purpose This paper aims to consider the nature of cannabis-related harms under the UK’s Misuse of Drugs Act (MDA). Written for the specific context of this four-paper special section on 50 years of the MDA, it argues that the MDA may cause more harm than it prevents. Design/methodology/approach An opinion piece offering a structured overview of cannabis-related harms under prohibition. It summarises existing evidence of the ways in which prohibition may exacerbate existing – and create new – harms related to the production, distribution, use and control of cannabis. Findings The paper argues that prohibition of cannabis under the MDA may cause more harm than it prevents. Originality/value It has long been argued that the MDA does not accurately or fairly reflect the harms of the substances it prohibits, and much existing research points to different ways in which drug prohibition can itself be harmful. The originality of this paper lies in bringing together these arguments and developing a framework for analysing the contribution of prohibition to drug-related harm.

show abstract